AlzeCure Pharma ABStockholm

LEI 5493001EJLEBXFY6I446 · XSTO · SE · Business ID 559094-8302

Recent insider sentiment

No open-market buying or selling — last 90 days

Share-award batches are excluded from this read — they’re compensation, not conviction.

0
Open-market buys (90d)
0
Sales (90d)
0
Share awards (90d)
5
Active insiders (90d)

Transactions

DatePersonNatureVolumePriceValueSource
02.07.2026
New shares (subscription)
184,914SEK 1.31
SEK 242,237.34
01.07.2026
Pontus ForsellManagement
New shares (subscription)
194,940SEK 1.31
SEK 255,371.40
30.06.2026
Thomas PollareBoard member
New shares (subscription)
240,625SEK 1.31
SEK 315,218.75
30.06.2026
Oncolution ABBoard member
New shares (subscription)
327,406SEK 1.31
SEK 428,901.86
26.06.2026
Johan SandinManagement
New shares (subscription)
177,275SEK 1.31
SEK 232,230.25
25.08.2025
Bought — open marketAcquisition
8,067SEK 2.19
SEK 17,666.73
30.07.2025
New shares (subscription)
55,624SEK 2.20
SEK 122,372.80
29.07.2025
New shares (subscription)
23,759SEK 2.20
SEK 52,269.80
28.07.2025
Johan SandinManagement
New shares (subscription)
4,545SEK 2.20
SEK 9,999.00
25.07.2025
New shares (subscription)
178,549SEK 2.20
SEK 392,807.80
24.07.2025
Jan LundbergBoard member
New shares (subscription)
150,000SEK 2.20
SEK 330,000.00
23.07.2025
Pontus ForsellManagement
Bought — open marketAcquisition
22,727SEK 2.20
SEK 49,999.40
23.07.2025
Thomas PollareBoard member
New shares (subscription)
568,030SEK 2.20
SEK 1,249,666.00

Active insiders (90d)

Oncolution AB
Board member
327,406 shares
1 filing
Thomas Pollare
Board member
240,625 shares
1 filing
Pontus Forsell
Management
194,940 shares
1 filing
184,914 shares
1 filing
Johan Sandin
Management
177,275 shares
1 filing

Insiders on file